<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Maintenance phase</Head00><Stub><StubValue>Mean % of time patients received a propofol infusion (range) during the maintenance phase</StubValue></Stub><HeaderValue>Remifentanil (n = 77)</HeaderValue></NavigationPath><value>62.8 (3.8â€“98.9)</value><CellType>Partially Numeric</CellType></Cell><Table><TableType>Subheader</TableType><tableName>Exposure to study opioids and propofol during the maintenance phase (intent to treat population)</tableName><tableOrder>Table 5</tableOrder><tableFooter/></Table><Document><DocumentTitle>Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]</DocumentTitle><PMC>420059</PMC></Document></information>
